WASHINGTON (dpa-AFX) - Tuesday, Rigel Pharmaceuticals, Inc. (RIGL) appointed Lisa Rojkjaer, as executive vice president and chief medical officer.
Rojkjaer, a board-certified hematologist with an international clinical practice background, previously held the position of Chief Medical Officer at Sangamo Therapeutics.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX